These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 22785518)

  • 1. Assessment of ovarian teratoma and lymphadenopathy by 18F-FDG PET/CT.
    Balink H; Apperloo MJ; Collins J
    Clin Nucl Med; 2012 Aug; 37(8):804-6. PubMed ID: 22785518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The usefulness of 18F-FDG-PET/CT in discriminating benign from malignant ovarian teratomas.
    Yokoyama T; Takehara K; Yamamoto Y; Okame S; Shiroyama Y; Yokoyama T; Nogawa T; Sugawara Y
    Int J Clin Oncol; 2015 Oct; 20(5):960-6. PubMed ID: 25681878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of 18F-FDG PET/CT in characterizing ovarian lesions and staging ovarian cancer: correlation with transvaginal ultrasonography, computed tomography, and histology.
    Castellucci P; Perrone AM; Picchio M; Ghi T; Farsad M; Nanni C; Messa C; Meriggiola MC; Pelusi G; Al-Nahhas A; Rubello D; Fazio F; Fanti S
    Nucl Med Commun; 2007 Aug; 28(8):589-95. PubMed ID: 17625380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 18F-FDG PET/CT Brain Imaging on a Patient With Paraneoplastic Opsoclonus-Myoclonus Syndrome Arising out of a Mature Cystic Teratoma.
    Na CJ; Jeong YJ; Lim ST; Sohn MH; Jeong HJ
    Clin Nucl Med; 2016 Feb; 41(2):e104-6. PubMed ID: 26545025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
    Ouyang L; Shi ZY; Lin ZG
    Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG-PET/CT as a molecular biomarker in ovarian cancer.
    Nowosinska E; Avril S; Murray I; Szyszko T; Avril N
    Cancer Biomark; 2010-2011; 8(4-5):167-75. PubMed ID: 22045351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoma of the ovary: additional role of 18F-FDG PET/CT.
    Santhosh S; Mittal BR; Raveendran A; Jain V; Nijhawan R; Kumar R; Bhattacharya A; Sharma SC
    Clin Nucl Med; 2013 May; 38(5):e230-2. PubMed ID: 23377413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The additional value of attenuation correction CT acquired during 18F-FDG PET/CT in differentiating mature from immature teratomas.
    Cho A; Kim SW; Choi J; Kang W; Lee JD; Yun M
    Clin Nucl Med; 2014 Mar; 39(3):e193-6. PubMed ID: 23989446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT in serous psammocarcinoma of the ovary.
    Dong A; Wang Y; Zuo C
    Clin Nucl Med; 2014 May; 39(5):453-5. PubMed ID: 23510884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The application of 18F-FDG PET/CT in ovarian immature teratomas when pathological examination results contradict clinical observations: a case report.
    Wang M; Jiang S; Zhang Y; Jiang C; Xia F; Lyu W; Ma X
    Medicine (Baltimore); 2017 Dec; 96(50):e9171. PubMed ID: 29390326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma.
    Abe Y; Tamura K; Sakata I; Ishida J; Ozeki Y; Tamura A; Uematsu K; Sakai H; Goya T; Kanazawa M; Machida K
    Oncol Rep; 2012 Feb; 27(2):333-8. PubMed ID: 22024889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT findings of mature cystic teratoma with malignant transformation: comparison with mature cystic teratoma.
    Park SB; Cho KS; Kim JK
    Clin Imaging; 2011; 35(4):294-300. PubMed ID: 21724123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcoidosis mimicking metastatic gynaecological malignancies: a diagnostic and therapeutic challenge?
    Mapelli P; Mangili G; Picchio M; Rabaiotti E; Gianolli L; Messa C; Candiani M
    Rev Esp Med Nucl Imagen Mol; 2013; 32(5):314-7. PubMed ID: 23270913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer.
    Zytoon AA; Murakami K; Eid H; El-Gammal M
    Acta Radiol; 2013 Apr; 54(3):340-8. PubMed ID: 23319725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.
    De Iaco P; Musto A; Orazi L; Zamagni C; Rosati M; Allegri V; Cacciari N; Al-Nahhas A; Rubello D; Venturoli S; Fanti S
    Eur J Radiol; 2011 Nov; 80(2):e98-103. PubMed ID: 20688446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneal and Nodal Gliomatosis Mimicking Metastasis on FDG PET/CT in a Patient With Ovarian Immature Teratoma.
    Lee SM; Choi MC; Lee JW; Kim T; Jang SJ
    Clin Nucl Med; 2023 Aug; 48(8):707-709. PubMed ID: 37220221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDG PET/CT of a benign ovarian Brenner tumor.
    Toriihara A; Taniguchi Y; Negi M; Kubota K; Makino T; Shibuya H
    Clin Imaging; 2012; 36(5):650-3. PubMed ID: 22920385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-Fluorodeoxyglucose Uptake in Anti-N-Methyl-D-Aspartate-Receptor Encephalitis Associated With an Immature Teratoma.
    Nakamoto R; Nakamoto Y; Ishimori T; Fushimi Y; Togashi K
    Clin Nucl Med; 2017 Feb; 42(2):157-160. PubMed ID: 27922872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative 18F-2-fluorodeoxyglucose PET/CT predicts good cancer specific survival in patients with a suspicion of recurrent ovarian cancer.
    Hebel CB; Behrendt FF; Heinzel A; Krohn T; Mottaghy FM; Bauerschlag DO; Verburg FA
    Eur J Radiol; 2014 Mar; 83(3):463-7. PubMed ID: 24368010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG PET/CT imaging features of Rosai Dorfman disease: a rare cause of massive generalized lymphadenopathy.
    Karunanithi S; Singh H; Sharma P; Naswa N; Kumar R
    Clin Nucl Med; 2014 Mar; 39(3):268-9. PubMed ID: 24217542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.